MedKoo Cat#: 561606 | Name: Tiamenidine
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Tiamenidine is a centrally-acting alpha1 adrenergic receptor antagonist.

Chemical Structure

Tiamenidine
Tiamenidine
CAS#31428-61-2

Theoretical Analysis

MedKoo Cat#: 561606

Name: Tiamenidine

CAS#: 31428-61-2

Chemical Formula: C8H10ClN3S

Exact Mass: 215.0284

Molecular Weight: 215.69

Elemental Analysis: C, 44.55; H, 4.67; Cl, 16.43; N, 19.48; S, 14.86

Price and Availability

Size Price Availability Quantity
10mg USD 500.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Tiamenidine; Hoe-440;
IUPAC/Chemical Name
N-(2-Chloro-4-methylthiophen-3-yl)-4,5-dihydro-1H-imidazol-2-amine
InChi Key
CVWILQHZFWRYPB-UHFFFAOYSA-N
InChi Code
InChI=1S/C8H10ClN3S/c1-5-4-13-7(9)6(5)12-8-10-2-3-11-8/h4H,2-3H2,1H3,(H2,10,11,12)
SMILES Code
CC1=CSC(Cl)=C1NC2=NCCN2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 215.69 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Opitz K. The effect of clonidine and related substances on voluntary ethanol consumption in rats. Drug Alcohol Depend. 1990 Feb;25(1):43-8. doi: 10.1016/0376-8716(90)90139-6. PMID: 1969792. 2: Kwon YW, Zhong Q, Wei XY, Zheng W, Triggle DJ. The interactions of 1,4-dihydropyridines bearing a 2-(2-aminoethylthio)methyl substituent at voltage-dependent Ca2+ channels of smooth muscle, cardiac muscle and neuronal tissues. Naunyn Schmiedebergs Arch Pharmacol. 1990 Jan-Feb;341(1-2):128-36. doi: 10.1007/BF00195069. PMID: 2156174. 3: Roden DM, Nadeau JH, Primm RK. Electrophysiologic and hemodynamic effects of chronic oral therapy with the alpha 2-agonists clonidine and tiamenidine in hypertensive volunteers. Clin Pharmacol Ther. 1988 Jun;43(6):648-54. doi: 10.1038/clpt.1988.90. PMID: 2897889. 4: Kobinger W. Rudolf Buchheim lecture. Drugs as tools in research on adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1986 Feb;332(2):113-23. doi: 10.1007/BF00511400. PMID: 3010138. 5: Struthers AD, Dollery CT. Central nervous system mechanisms in blood pressure control. Eur J Clin Pharmacol. 1985;28 Suppl:3-11. doi: 10.1007/BF00543703. PMID: 2865146. 6: Hamilton BP, Mersey JH, Hamilton J, Kuzbida G, Pavlis R, Levinson P. Withdrawal phenomena in subjects with essential hypertension on clonidine or tiamenidine. Clin Pharmacol Ther. 1984 Nov;36(5):628-33. doi: 10.1038/clpt.1984.232. PMID: 6488684. 7: Reid JL, Campbell BC, Hamilton CA. Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists. Hypertension. 1984 Sep-Oct;6(5 Pt 2):II71-5. doi: 10.1161/01.hyp.6.5_pt_2.ii71. PMID: 6150002. 8: Roach AG, Doxey JC, Strachan DA, Cavero I. Sleeping times evoked by alpha adrenoceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoceptors. J Pharmacol Exp Ther. 1983 Nov;227(2):421-8. PMID: 6138427. 9: Doxey JC, Frank LW, Hersom AS. Studies on the pre- and postjunctional activities of alpha-adrenoreceptor agonists and their cardiovascular effects in the anaesthetized rat. J Auton Pharmacol. 1981 Mar;1(2):157-69. doi: 10.1111/j.1474-8673.1981.tb00508.x. PMID: 6121811. 10: Eckert HG, Baudner S, Weimer KE, Wissmann H. Determination of tiamenidine in biological specimens by radioimmunoassay. Arzneimittelforschung. 1981;31(3):419-24. PMID: 7194666. 11: Hansson BG, Hökfelt B. Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine. Br J Clin Pharmacol. 1981 Jan;11(1):73-7. doi: 10.1111/j.1365-2125.1981.tb01105.x. PMID: 7011348; PMCID: PMC1401688. 12: Summers RJ, Jarrott B, Louis WJ. Selectivity of a series of clonidine-like drugs for alpha 1 and alpha 2 adrenoceptors in rat brain. Neurosci Lett. 1980 Dec;20(3):347-50. doi: 10.1016/0304-3940(80)90172-x. PMID: 6255379. 13: Campbell BC, Elliott HL, Hamilton CA, Reid JL. Changes in blood pressure, heart rate, and sympathetic activity on abrupt withdrawal of tiamenidine (HOE 440) in essential hypertension. Eur J Clin Pharmacol. 1980 Nov;18(6):449-54. doi: 10.1007/BF00874654. PMID: 7461012. 14: Summers RJ, Jarrott B, Louis WJ. Displacement of [3H]clonidine binding by clonidine analogues in membranes from rat cerebral cortex. Eur J Pharmacol. 1980 Aug 29;66(2-3):233-41. doi: 10.1016/0014-2999(80)90147-8. PMID: 6254785. 15: Finch L, Hicks PE. Cardiovascular withdrawal effects of clonidine and tiamenidine on abrupt cessation of oral treatment in conscious cats. J Pharm Pharmacol. 1980 Apr;32(4):272-7. doi: 10.1111/j.2042-7158.1980.tb12911.x. PMID: 6103057. 16: Gerlis LS, Wright N. Abrupt withdrawal of the antihypertensive agent tiamenidine after 12-months' treatment. Pharmatherapeutica. 1980;2(6):408-11. PMID: 7001495. 17: Zamboulis C, Hossmann V, Dollery CT, Eckert H. Tiamenidine, a centrally acting antihypertensive drug in essential hypertension [proceedings]. Br J Clin Pharmacol. 1979 Oct;8(4):390P. PMID: 508528. 18: Doxey JC. Pre- and postsynaptic effects of alpha-agonists in the anococcygeus muscle of the pithed rat. Eur J Pharmacol. 1979 Feb 15;54(1-2):185-9. doi: 10.1016/0014-2999(79)90423-0. PMID: 33816. 19: Zapata AM, García MP, Cabrera AS, García MR. Effects of centrally applied thiamenidine on pressure response to central nervous system stimulation. Cor Vasa. 1979;21(1):71-8. PMID: 477332. 20: Bryce TA, Burrows JL. Quantitative analysis of tiamenidine in human plasma by gas chromatography mass spectrometry of a dibenzyl derivative. Biomed Mass Spectrom. 1979 Jan;6(1):27-30. doi: 10.1002/bms.1200060107. PMID: 427259.